Unterehmen auf Watchlist setzen
UnitedHealth
ISIN: US91324P1021
WKN: 869561
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

UnitedHealth · ISIN: US91324P1021 · PR Newswire (ID: 20240708LA54645)
08 Juli 2024 06:00PM

UNH Investors Have Opportunity to Lead UnitedHealth Group Incorporated Securities Fraud Lawsuit


LOS ANGELES, July 8, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against UnitedHealth Group Incorporated ("UnitedHealth" or the "Company") (NYSE: UNH).

Class Period: March 14, 2022February 27, 2024

Lead Plaintiff Deadline: July 15, 2024

If you wish to serve as lead plaintiff of the UnitedHealth lawsuit, you can submit your contact information at www.glancylaw.com/cases/UnitedHealth-Group-Incorporated/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors that: (1) UnitedHealth never established proper firewalls between Optum and UnitedHealthcare as required by its own policy, and as it told the court in the antitrust action, the DOJ and investors it would do; (2) Firewalls were never properly created for certain business applications; (3) Despite assurances to the contrary, there was never a meaningful technological separation between Optum and UnitedHealthcare that prevented the sharing of customer sensitive information; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.  If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts 

Glancy Prongay & Murray LLP, Los Angeles

Charles Linehan, 310-201-9150 or 888-773-9224

shareholders@glancylaw.com

www.glancylaw.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/unh-investors-have-opportunity-to-lead-unitedhealth-group-incorporated-securities-fraud-lawsuit-302189368.html

SOURCE Glancy Prongay & Murray LLP

Visuelle Wertentwicklung / Kursverlauf · UnitedHealth
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942